Alphawave IP Announces New Appointments & more…Keep up with what has been happening this week in our latest IP news round-up…

MINTangible takes on NFT intellectual property chaos with the introduction of a revolutionary NFT IP Rights Solution

MINTangible, the leading company dedicated to Web3 intellectual property and rights management, has launched a groundbreaking blockchain solution that enables brands and creators to digitally bind IP license and royalty terms to their non-fungible tokens (NFTs).


Alphawave IP Announces Appointments to its Executive Leadership team

The expanded leadership team will support the successful execution of Alphawave IP’s long-term strategy while continuing to deliver for customers and shareholders


Nanoco warns settlement in its IP lawsuit will be at ‘lower end of expectations’

Shares in Manchester tech business, Nanoco, fell by more than 15% in early trading this morning, following the latest update on its intellectual property lawsuit against South Korea electronics giant Samsung.


RenovoRx Strengthens Intellectual Property (IP) Portfolio with Eighth US Patent

RenovoRx, Inc., a biopharmaceutical company focused on the localised treatment of difficult-to-treat solid tumors, today announced that on January 3, 2023 the United States Patent and Trademark Office issued US patent number 11,541,211 broadly covering methods for treating cholangiocarcinoma (bile duct cancer) by selectively delivering one or more therapeutic agents into targeted regions of the bile duct. This is RenovoRx’s eighth US patent.

 

Back to Top

Get the latest jobs